BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 32233072)

  • 1. A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer.
    Xiang W; Rao H; Zhou L
    Thorac Cancer; 2020 Jun; 11(6):1423-1432. PubMed ID: 32233072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
    Tang S; Xiang C; Yang Q
    Br J Radiol; 2020 Aug; 93(1112):20200301. PubMed ID: 32574075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
    Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
    J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced spectral mammography: A potential exclusion diagnosis modality in dense breast patients.
    Qin Y; Liu Y; Zhang X; Zhao S; Zhong H; Huang J; Yu J
    Cancer Med; 2020 Apr; 9(8):2653-2659. PubMed ID: 32074407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
    Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
    Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts.
    Lu Z; Hao C; Pan Y; Mao N; Wang X; Yin X
    Korean J Radiol; 2020 Apr; 21(4):442-449. PubMed ID: 32193892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme.
    Lobbes MB; Lalji U; Houwers J; Nijssen EC; Nelemans PJ; van Roozendaal L; Smidt ML; Heuts E; Wildberger JE
    Eur Radiol; 2014 Jul; 24(7):1668-76. PubMed ID: 24696228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between breast MRI and contrast-enhanced spectral mammography.
    Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
    Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size.
    Fallenberg EM; Dromain C; Diekmann F; Engelken F; Krohn M; Singh JM; Ingold-Heppner B; Winzer KJ; Bick U; Renz DM
    Eur Radiol; 2014 Jan; 24(1):256-64. PubMed ID: 24048724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Contrast-Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta-analysis.
    Zhu X; Huang JM; Zhang K; Xia LJ; Feng L; Yang P; Zhang MY; Xiao W; Lin HX; Yu YH
    Clin Breast Cancer; 2018 Oct; 18(5):e985-e995. PubMed ID: 29983379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.
    Travieso-Aja MDM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Vega Benítez V; Pérez-Luzardo O
    Radiol Med; 2019 Oct; 124(10):1006-1017. PubMed ID: 31250270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: A systematic review and meta-analysis.
    Suter MB; Pesapane F; Agazzi GM; Gagliardi T; Nigro O; Bozzini A; Priolo F; Penco S; Cassano E; Chini C; Squizzato A
    Breast; 2020 Oct; 53():8-17. PubMed ID: 32540554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for breast cancer detection: An update meta-analysis.
    Dong H; Kang L; Cheng S; Zhang R
    Thorac Cancer; 2021 Dec; 12(23):3201-3207. PubMed ID: 34668649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRI.
    Daniaux M; Gruber L; De Zordo T; Geiger-Gritsch S; Amort B; Santner W; Egle D; Baltzer PAT
    Eur J Radiol; 2023 Jun; 163():110838. PubMed ID: 37080064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging.
    Luczynska E; Pawlak M; Piegza T; Popiela TJ; Heinze S; Dyczek S; Rudnicki W
    Ginekol Pol; 2021; 92(2):92-97. PubMed ID: 33448005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
    Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
    AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
    Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
    Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Contrast-Enhanced Spectral Mammography and Contrast-Enhanced MRI in Screening Multifocal and Multicentric Lesions in Breast Cancer Patients.
    Feng L; Sheng L; Zhang L; Li N; Xie Y
    Contrast Media Mol Imaging; 2022; 2022():4224701. PubMed ID: 35585943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced spectral mammography in patients with MRI contraindications.
    Richter V; Hatterman V; Preibsch H; Bahrs SD; Hahn M; Nikolaou K; Wiesinger B
    Acta Radiol; 2018 Jul; 59(7):798-805. PubMed ID: 29058963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.